Photo of Che-Kai Tsao

Che-Kai Tsao

  • ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Print ProfilePrint Profile

Certifications

  • Medical Oncology

  • American Board of Internal Medicine

Education

  • MD, SUNY Downstate Medical Center

  • Residency, Internal Medicine
    Long Island Jewish Medical Center

  • Fellowship, Hematology/Oncology
    Mount Sinai Hospital

Biography

    Che-Kai Tsao, MD is an Assistant Professor of Hematology and Medical Oncology at the Tisch Cancer Institute, Mount Sinai Medical Center.

    Dr. Tsao's clinical interest includes management of all cancers, including breast, blood (plasma cell disorders, myelodysplastic syndrome, myeloproliferative disorders), gastrointestinal, genitourinary, lymphoma, thoracic, skin, neurologic, head/neck, neuroendocrine, bone, and soft tissue tumors. Dr. Tsao is also interested in the management of various blood disorders, including coagulopathy, thromboembolic diseases, and blood cell disorders.

     

Awards

  • 2012 -
    Physician of the Year, Fellow Award
    Mount Sinai Hospital

  • 2012 -
    GU Cancers Merit Award
    American Society of Clinical Oncology

  • 2012 -
    Merit Award
    American Society of Clinical Oncology

  • 2011 -
    Workshop on Methods in Clinical Cancer Research
    ASCO/AACR

  • 2011 -
    Oncology Trainee Travel Award
    American Society of Clinical Oncology

Research

Genitourinary Cancers

Prostate Cancer, Kidney Cancer, Bladder Cancer, Testicular Cancer, and Adrenal Cancer.

Publications

Tsao C, Galsky MD, Small AC, Yee T, Oh WK. Targeting the Androgen Receptor Signaling Axis in Castration Resistant Prostate Cancer. British Journal of Urology-International;.

Tsao C, Seng SM, Galsky MD, Oh WK. Endocrine therapy for prostate cancer: review of the latest clinical evidence. Clinical Investigation 2011 April; 1(4): 533-541.

Small AC, Tsao CK, Moshier EL, Gartrell BA, Wisnivesky JP, Godbold JH, Smith CB, Sonpavde G, Oh WK, Galsky MD. Prevalence and characteristics of patients with metastatic cancer who receive no anticancer therapy. Cancer 2012 Jun;.

Tsao CK, Small AC, Moshier EL, Gartrell BA, Wisnivesky JP, Sonpavde G, Godbold JH, Palese MA, Hall SJ, Oh WK, Galsky MD. Trends in the Use of Cytoreductive Nephrectomy in the United States. Clinical genitourinary cancer 2012 May;.

Galsky MD, Small AC, Tsao CK, Oh WK. Clinical development of novel therapeutics for castration-resistant prostate cancer: Historic Challenges and Recent Successes. CA: a cancer journal for clinicians 2012 Apr;.

Gartrell BA, Tsao CK, Galsky MD. The follicle-stimulating hormone receptor: A novel target in genitourinary malignancies. Urologic oncology 2012 Apr;.

Tsao CK, Small AC, Galsky MD, Oh WK. Overcoming castration resistance in prostate cancer. Current opinion in urology 2012 May; 22(3).

Tsao CK, Moshier E, Seng SM, Godbold J, Grossman S, Winston J, Oh WK, Galsky MD. Impact of the CKD-EPI equation for estimating renal function on eligibility for cisplatin-based chemotherapy in patients with urothelial cancer. Clinical genitourinary cancer 2012 Mar; 10(1).

Tsao CK, Seng S, Oh WK, Galsky MD. Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer. Clinical Medicine Insights. Oncology 2011; 5.

Tsao CK, Oh WK. Selective cell death mediated by small conditional RNAs: a novel therapeutic approach to cancer therapy. Asian journal of andrology 2011 Mar; 13(2).

Small AC, Tsao CK, Moshier EL, Gartrell BA, Wisnivesky JP, Godbold J, Sonpavde G, Palese MA, Hall SJ, Oh WK, Galsky MD. Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United States. World journal of urology 2012 May;.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr.Tsao is not currently required to report Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Ruttenberg Treatment Center

1470 Madison Avenue
3rd floor
New York, NY 10029

Tel: 212-241-6756
Fax: 212-659-5599
Get Directions

Office Hours:
  • Friday 9:00am - 1:00pm

Mount Sinai Queens-Physician Associates

27-15 30th Avenue
Astoria, NY 11102

Tel: 718-278-3569
Fax: 718-278-2941
Get Directions

Office Hours:
  • Monday 8:00am - 4:30pm
  • Tuesday 8:00am - 4:30pm
  • Wednesday 8:00am - 4:30pm
  • Thursday 8:00am - 4:30pm
  • Friday 8:00am - 4:30pm